Advertisement

Organisation › Details
Thermo Fisher (Group)
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of nearly $11 billion, we have approximately 37,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications. *
![]() |
Start | 2006-11-09 merged |
Predecessor | Thermo Electron (Group) | |
![]() |
Industry | laboratory equipment and instruments |
Industry 2 | reagents (bio/biochemical) | |
![]() |
Person | Casper, Marc N. (Thermo Fisher 200910– CEO before 200805– COO joined Thermo 12/01 before Kendro CEO before Dade Behring) |
![]() |
Region | Waltham, MA |
Country | United States (USA) | |
Street | 168 Third Avenue | |
City | Waltham, MA | |
Tel | +1-781-622-1000 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | H: 10,001 to 50,00 (2015-01-29) |
Currency | USD | |
Annual sales | 25,542,000,000 (revenues, consolidated (2019) 2019-12-31) | |
Profit | 3,696,000,000 (2019-12-31) | |
Cash | 2,399,000,000 (2019-12-31) | |
* Document for »About Section«: | ||
Record changed: 2023-10-09 |
Advertisement

More documents for Thermo Fisher (Group)
- [1] miDiagnostics N.V.. (12/4/24). "Press Release: miDiagnostics Secures €30 Million Series D Funding Round Led by Thermo Fisher Scientific to Advance an Innovative Sterility Test and Other Quality Control Tests for use in the BioPharma Industry". Leuven....
- [2] Broken String Biosciences Ltd.. (7/24/24). "Press Release: Broken String Biosciences Appoints Steve Becker as Chief Commercial Officer". Cambridge....
- [3] Tecan Group Ltd.. (6/24/24). "Press Release: Tecan Appoints Mukta Acharya Head of the Life Sciences Business Division". Männedorf....
- [4] Thermo Fisher Scientific Inc.. (10/17/23). "Press Release: Thermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation Proteomics". Waltham, MA & Uppsala....
- [5] Exothera S.A.. (2/1/23). "Press Release: Exothera Announces the Appointment of Darren Leva as Chief Business Officer". Jumet....
- [6] Thermo Fisher Scientific Inc.. (10/31/22). "Press Release: Thermo Fisher Scientific to Acquire The Binding Site Group". Waltham, MA....
- [7] Element Biosciences, Inc.. (5/23/22). "Press Release: Element Appoints Mark Aitkenhead, PhD, as Chief Commercial Officer"....
- [8] Yposkesi. (2/28/22). "Press Release: Yposkesi, an SK pharmteco Company, Appoints US-based Executive Director for Business Development". Corbeil-Essonnes....
- [9] Thermo Fisher Scientific Inc.. (1/4/22). "Press Release: Thermo Fisher Scientific to Present at the 40th Annual J.P. Morgan Healthcare Conference". Waltham, MA....
- [10] Bico Group AB. (11/15/21). "Press Release: Cellenion Announces Co-marketing Agreement for Single Cell Mass Spectrometry-based Proteomics Analysis"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top